// App-Quantinova.ai

: Evaluation of DestiNA ‘spin-tube’ technology – a novel test for the diagnosis of tuberculosis and mycobacteriosis

Researchers

Presenter

  • Tatiana Smirnova

Principal Investigators

  • Elena Larionova

  • Irina Andrievskaya

  • Ekaterina Kiseleva

  • Larisa Chernousova

  • Atadzhan Ergeshov

  • Juan Diaz Mochon

  • Mavys Trabue

  • Salvatore Pernagallo

  • Mario Antonio Fara

  • Antonio Martínez-Murcia

  • Adrian Garcia Sirera

  • Aaron Navarro Garcia

  • Riccardo Manganelli

  • Luisa Barzon

  • Alessandro Sinigaglia

  • Mark Bradley

  • Daniel Norman

  • Seshasailam Venkateswaran

Medical Centers

  • Central Tuberculosis Recearch Institute, Moscow, Russian Federation

  • Destina Genomics, Granada, Spain

  • Genetic Analysis Strategies, Elche, Spain

  • University of Pavia, Pavia, Italy

  • The University of Edinburgh, Edinburgh, United Kingdom

Locations

  • Russia

  • Spain

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved